Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Tomas Vaisar, … , John F. Oram, Jay W. Heinecke
Tomas Vaisar, … , John F. Oram, Jay W. Heinecke
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):746-756. https://doi.org/10.1172/JCI26206.
View: Text | PDF
Research Article Article has an altmetric score of 20

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

  • Text
  • PDF
Abstract

HDL lowers the risk for atherosclerotic cardiovascular disease by promoting cholesterol efflux from macrophage foam cells. However, other antiatherosclerotic properties of HDL are poorly understood. To test the hypothesis that the lipoprotein carries proteins that might have novel cardioprotective activities, we used shotgun proteomics to investigate the composition of HDL isolated from healthy subjects and subjects with coronary artery disease (CAD). Unexpectedly, our analytical strategy identified multiple complement-regulatory proteins and a diverse array of distinct serpins with serine-type endopeptidase inhibitor activity. Many acute-phase response proteins were also detected, supporting the proposal that HDL is of central importance in inflammation. Mass spectrometry and biochemical analyses demonstrated that HDL3 from subjects with CAD was selectively enriched in apoE, raising the possibility that HDL carries a unique cargo of proteins in humans with clinically significant cardiovascular disease. Collectively, our observations suggest that HDL plays previously unsuspected roles in regulating the complement system and protecting tissue from proteolysis and that the protein cargo of HDL contributes to its antiinflammatory and antiatherogenic properties.

Authors

Tomas Vaisar, Subramaniam Pennathur, Pattie S. Green, Sina A. Gharib, Andrew N. Hoofnagle, Marian C. Cheung, Jaeman Byun, Simona Vuletic, Sean Kassim, Pragya Singh, Helen Chea, Robert H. Knopp, John Brunzell, Randolph Geary, Alan Chait, Xue-Qiao Zhao, Keith Elkon, Santica Marcovina, Paul Ridker, John F. Oram, Jay W. Heinecke

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 8 14 15 24 17 25 17 25 15 24 30 22 34 41 27 35 28 14 6 421
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (421)

Title and authors Publication Year
Increased pro-SFTPB in HDL promotes the pro-inflammatory transition of HDL and represents a sign of poor prognosis in ARDS patients
Yang L, Xu Z, Wang Z, Ding F, Wu Z, Shi X, Wang J, Ma Y, Jin J
Journal of Translational Medicine 2025
The association between neutrophil to high-density lipoprotein cholesterol ratio and gallstones: a cross-sectional study
Wang Y, Shang X, Zhang Y, Zhang Y, Shen W, Wu Q, Du W
BMC Public Health 2025
Association between the atherogenic index of plasma and long-term risk of type 2 diabetes: a 12-year cohort study based on the Japanese population
Zhou Q, Wu Y, Li M
Cardiovascular Diabetology 2025
High-Density Lipoprotein Lipid and Protein Cargo and Cholesterol Efflux Capacity before and after Bariatric Surgery
Zahid S, Schlamp F, Gildea MA, Lin BX, Chaloemtoem A, Falis M, Parikh M, Fisher EA, Hornemann T, Vaisar T, Heffron SP
Arteriosclerosis, thrombosis, and vascular biology 2025
Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes
Shao B, Snell-Bergeon JK, de Boer IH, Davidson WS, Bornfeldt KE, Heinecke JW
Journal of Lipid Research 2025
Proteomic and lipidomic analysis of low-density lipoprotein identifies potential biomarkers of early estrogen receptor-positive breast cancer
Abu Mohsen Y, Twitto-Greenberg R, Cohen A, Leichner GS, Mahler L, Cohen H, Kamari Y, Shaish A, Harari A, Leikin-Frenkel A, Glick Saar E, Geiger T, Malitsky S, Itkin M, Harats D, Keshet R
Cancer & Metabolism 2025
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics
Nieddu G, Formato M, Lepedda AJ
Journal of Cardiovascular Development and Disease 2025
Association between serum uric acid to high-density lipoprotein cholesterol ratio (UHR) and abdominal aortic calcification: a cross-sectional study based on NHANES 2013–2014
Li B, Xu Y, He Q, Yin Q, Wu M, Zhu H, Cao Y
Frontiers in Cardiovascular Medicine 2025
High-Density Lipoprotein Metabolism and Function in Cardiovascular Diseases: What about Aging and Diet Effects?
Morvaridzadeh M, Zoubdane N, Heshmati J, Alami M, Berrougui H, Khalil A
Nutrients 2024
ANGPTL3 is a novel HDL component that regulates HDL function.
Yang L, Wang Y, Xu Y, Li K, Yin R, Zhang L, Wang D, Wei L, Lang J, Cheng Y, Wang L, Ke J, Zhao D
Journal of Translational Medicine 2024
Fish Oil Supplementation Modifies the Proteome, Lipidome, and Function of High-Density Lipoprotein: Findings from a Trial in Young Healthy Adults.
Mueller PA, Bergstrom P, Rosario S, Heard M, Pamir N
The Journal of nutrition 2024
Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study
Maravi JS, Leszczynski EC, Schwartz CS, Dev PK, Barber JL, Reasons RJ, Pearce RW, McPhaul MJ, Konrad RJ, Robbins JM, Gerszten RE, Collier TS, Bouchard C, Rohatgi A, Sarzynski MA
Atherosclerosis 2024
Bridging the Gap Between the Bench and Bedside: Clinical Applications of High-density Lipoprotein Function
Endo Y, Sasaki K, Ikewaki K
Journal of Atherosclerosis and Thrombosis 2024
Enhancement of high-density lipoprotein-associated protease inhibitor activity prevents atherosclerosis progression
Mobilia M, Karakashian A, Neupane KR, Hage O, Whitus C, Carter A, Voy C, Johnson LA, Graf GA, Gordon SM
Atherosclerosis 2024
Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
Tang S, Yang J, Xiao B, Wang Y, Lei Y, Lai D, Qiu Q
Investigative Ophthalmology & Visual Science 2024
High-density lipoprotein cholesterol and nasal colonization of Staphylococcus aureus: results from the 2001-2004 National Health and Nutrition Examination Survey (NHANES).
Wen J, Zhang Z
BMC infectious diseases 2024
Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.
Vaisar T, Babenko I, Horvath KV, Niisuke K, Asztalos BF
Atherosclerosis 2024
Interplay between Lipids and Complement Proteins—How Multiomics Data Integration Can Help Unravel Age-related Macular Degeneration Pathophysiology: A Proof-of-concept Study
Nusinovici S, Zhou L, Raghavan L, Tham YC, Li H, Cheung D, Wang X, Cheung CM, Wong TY, Chakravarthy U, Cheng CY
Ophthalmology Science 2024
Nuclear Magnetic Resonance Analysis Implicates Sex-Specific Dysregulation of the Blood Lipids in Alzheimer’s Disease: A Retrospective Health-Controlled Study
Li Y, Yu X, Ma Z, Liu Q, Li M, Tian X, Li B, Zhang R, Gu P, Bai F, Luo G, Li M, Sun D
Psychiatry Investigation 2024
The complement system in lipid-mediated pathologies
Alic L, Dendinovic K, Papac-Milicevic N
Frontiers in Immunology 2024
Lipid-lowering drug and complement factor H genotyping–personalized treatment strategy for age-related macular degeneration
Xue CC, Teo KY, Tham YC, Li H, Thakur S, Sabanayagam C, Fan Q, Silver DL, Wang X, Cheung CM, Wong TY, Chakravarthy U, Cheng CY, Nusinovici S
iScience 2024
Type I IFN induces long-chain acyl-CoA synthetase 1 to generate a phosphatidic acid reservoir for lipotoxic saturated fatty acids
Barnhart S, Shimizu-Albergine M, Kedar E, Kothari V, Shao B, Krueger M, Hsu CC, Tang J, Kanter JE, Kramer F, Djukovic D, Pascua V, Loo YM, Colonna L, Van den Bogaerde SJ, An J, Gale M Jr, Reue K, Fisher EA, Gharib SA, Elkon KB, Bornfeldt KE
Journal of Lipid Research 2024
Consuming High-Fat and Low-Fat Ground Beef Depresses High-Density and Low-Density Lipoprotein Cholesterol Concentrations, and Reduces Small, Dense Low-Density Lipoprotein Particle Abundance
Lytle JR, Price T, Crouse SF, Smith DR, Walzem RL, Smith SB
Nutrients 2023
Low HDL-Cholesterol Concentrations in Lung Transplant Candidates are Strongly Associated With One-Year Mortality After Lung Transplantation
Tanaka S, Tymowski CD, Tran-Dinh A, Meilhac O, Lortat-Jacob B, Zappella N, Jean-Baptiste S, Robert T, Goletto T, Godet C, Castier Y, Mal H, Mordant P, Atchade E, Messika J, Montravers P
Transplant International 2023
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
Kim HJ, Jeong S, Oh YH, Park SJ, Cho Y, Park SM
Cardiovascular Diabetology 2023
Remote ischemic conditioning-induced hyperacute and acute responses of plasma proteome in healthy young male adults: a quantitative proteomic analysis
Song S, Wu H, Liu Y, Lan D, Jiao B, Wan S, Guo Y, Zhou D, Ding Y, Ji X, Meng R
Chinese Medical Journal 2023
MIC26 and MIC27 are bona fide subunits of the MICOS complex in mitochondria and do not exist as glycosylated apolipoproteins
Lubeck M, Derkum NH, Naha R, Strohm R, Driessen MD, Belgardt BF, Roden M, Stühler K, Anand R, Reichert AS, Kondadi AK
PloS one 2023
Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study.
Huang C, Zhang J, Huang J, Li H, Wen K, Bao J, Wu X, Sun R, Abudukeremu A, Wang Y, He Z, Chen Q, Huang X, Wang H, Zhang Y
Lipids in Health and Disease 2023
Strategies for consistent and automated quantification of HDL proteome using data-independent acquisition
Souza Junior DR, Silva AR, Ronsein GE
Journal of lipid research 2023
Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health
Merrill NJ, Davidson WS, He Y, Díaz Ludovico I, Sarkar S, Berger MR, McDermott JE, Van Eldik LJ, Wilcock DM, Monroe ME, Kyle JE, Bruce KD, Heinecke JW, Vaisar T, Raber J, Quinn JF, Melchior JT
Science Advances 2023
Identification of the specific molecular and functional signatures of pre-beta-HDL: relevance to cardiovascular disease.
Guillas I, Lhomme M, Pionneau C, Matheron L, Ponnaiah M, Galier S, Lebreton S, Delbos M, Ma F, Darabi M, Khoury PE, Abifadel M, Couvert P, Giral P, Lesnik P, Guerin M, Le Goff W, Kontush A
Basic Research in Cardiology 2023
Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study
Yadegar A, Mohammadi F, Rabizadeh S, Meysamie A, Nabipoorashrafi SA, Seyedi SA, Esteghamati A, Nakhjavani M
PloS one 2023
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability
Nieddu G, Formato M, Lepedda AJ
International journal of molecular sciences 2023
High-density lipoprotein regulates angiogenesis by affecting autophagy via miRNA-181a-5p.
Kang BA, Li HM, Chen YT, Deng MJ, Li Y, Peng YM, Gao JJ, Mo ZW, Zhou JG, Ou ZJ, Ou JS
Science China Life Sciences 2023
Proteomic Determinants of Variation in Cholesterol Efflux: Observations from the Dallas Heart Study
Gangwar A, Deodhar SS, Saldanha S, Melander O, Abbasi F, Pearce RW, Collier TS, McPhaul MJ, Furtado JD, Sacks FM, Merrill NJ, McDermott JE, Melchior JT, Rohatgi A
International journal of molecular sciences 2023
Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population
Price TR, Emfinger CH, Schueler KL, King S, Nicholson R, Beck T, Yandell BS, Summers SA, Holland WL, Krauss RM, Keller MP, Attie AD
Journal of lipid research 2023
Asthmatics with High Serum Amyloid A have Pro-inflammatory HDL: Implications for Augmented Systemic and Airway Inflammation
Yao X, Kaler M, Qu X, Kalidhindi RS, Sviridov D, Dasseux A, Barr E, Keeran K, Jeffries KR, Yu ZX, Gao M, Gordon S, Barochia AV, Mills J, Shahid S, Weir NA, Kalchiem-Dekel O, Theard P, Playford MN, Stylianou M, Fitzgerald W, Remaley AT, Levine SJ
Journal of Allergy and Clinical Immunology 2023
Atherosclerosis: Methods and Protocols
D Ramji
2022
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
G Marsche, J Stadler, J Kargl, M Holzer
Antioxidants 2022
The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy
Yongzheng Lu, Xiaolin Cui, Li Zhang, Xu Wang, Yanyan Xu, Zhen Qin, Gangqiong Liu, Qiguang Wang, Kang Tian, Khoon S Lim, Chris J Charles, Jinying Zhang, Junnan Tang
Aging and disease 2022
The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function
WS Davidson, AS Shah, H Sexmith, SM Gordon
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2022
Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes
B Shao, J Snell-Bergeon, L Pyle, K Thomas, I de Boer, V Kothari, J Segrest, W Davidson, K Bornfeldt, J Heinecke
Journal of lipid research 2022
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
Kalayci A, Gibson CM, Ridker PM, Wright SD, Kingwell BA, Korjian S, Chi G, Lee JJ, Tricoci P, Kazmi SH, Fitzgerald C, Shaunik A, Berman G, Duffy D, Libby P
Current Atherosclerosis Reports 2022
HDL as Bidirectional Lipid Vectors: Time for New Paradigms
Luna-Luna M, Niesor E, Pérez-Méndez Ó
Biomedicines 2022
Quantitative glycoproteomics of high-density lipoproteins
Tang X, Wong M, Tena J, Zhu C, Rhodes C, Zhou Q, Vinjamuri A, Oloumi A, Boddu S, Luxardi G, Maverakis E, Lebrilla CB, Zivkovic AM
RSC Advances 2022
Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis
Tanaka S, De Tymowski C, Stern J, Bouzid D, Zappella N, Snauwaert A, Robert T, Lortat-jacob B, Tran-dinh A, Augustin P, Boutten A, Tashk P, Peoc\u2019h K, Meilhac O, Montravers P
PloS one 2022
Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease
Mayyas F, Bani Omar E
Heliyon 2022
The Influence of Clusterin Glycosylation Variability on Selected Pathophysiological Processes in the Human Body
Janiszewska E, Kmieciak A, Kacperczyk M, Witkowska A, Kratz EM
Oxidative medicine and cellular longevity 2022
Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Yanagi Y, Yu RM, Ahamed W, Yu M, Teo KY, Tan AC, Cheng CY, Wong TY, Apte RS, Cheung CM
2022
Lipoproteins and Calcific Aortic Valve Disease: Hardening Evidence?
O'Brien KD
Arteriosclerosis, thrombosis, and vascular biology 2022
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies.
Vyletelová V, Nováková M, Pašková Ľ
Pharmaceuticals (Basel, Switzerland) 2022
Calcium-induced environmental adaptability of the blood protein vitronectin.
Tian Y, Shin K, Aleshin AE, Im W, Marassi FM
Biophysical Journal 2022
Associations between Alcohol Consumption and HDL Subspecies Defined by ApoC3, ApoE and ApoJ: the Cardiovascular Health Study.
Wilkens TL, Sørensen H, Jensen MK, Furtado JD, Dragsted LO, Mukamal KJ
Current Problems in Cardiology 2022
CETP Inhibitors: Should We Continue to Pursue This Pathway?
Nicholls SJ, Nelson AJ
Current Atherosclerosis Reports 2022
HDL Isolated by Immunoaffinity, Ultracentrifugation, or Precipitation is Compositionally and Functionally Distinct
Holzer M, Ljubojevic-Holzer S, Souza Junior DR, Stadler JT, Rani A, Scharnagl H, Ronsein GE, Marsche G
Journal of lipid research 2022
Relationships between Lipid-Related Metabolites and Age-Related Macular Degeneration Vary with Complement Genotype
Sim RZ, Tham YC, Betzler BK, Zhou L, Wang X, Sabanayagam C, Cheung GC, Wong TY, Cheng CY, Nusinovici S
2022
Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume
Pedrini S, Doecke JD, Hone E, Wang P, Thota R, Bush AI, Rowe CC, Dore V, Villemagne VL, Ames D, Rainey\u2010Smith S, Verdile G, Sohrabi HR, Raida MR, Taddei K, Gandy S, Masters CL, Chatterjee P, Martins RN
Journal of Neurochemistry 2022
Clinicoradiological evaluation of oxidative stress activity in acute cerebral infarction in the first 24 h and the qualitative importance of dysfunctional HDL in stroke
DEMİR ÜNAL E, VURAL G, EREN F, NEŞELİOĞLU S, EREL Ö
2022
The small HDL particle hypothesis of Alzheimer’s disease
Martinez AE, Weissberger G, Kuklenyik Z, He X, Meuret C, Parekh T, Rees JC, Parks BA, Gardner MS, King SM, Collier TS, Harrington MG, Sweeney MD, Wang X, Zlokovic BV, Joe E, Nation DA, Schneider LS, Chui HC, Barr JR, Han SD, Krauss RM, Yassine HN
Alzheimer's & dementia : the journal of the Alzheimer's Association 2022
Associations of HDL subclasses and lipid content with complement proteins over the menopause transition: The SWAN HDL Ancillary Study
El Khoudary SR, Chen X, McConnell D, Brooks MM, Billheimer J, Orchard TJ
Journal of Clinical Lipidology 2022
Active antithrombin glycoforms are selectively physiosorbed on plasma extracellular vesicles
Radeghieri A, Alacqua S, Zendrini A, Previcini V, Todaro F, Martini G, Ricotta D, Bergese P
2022
Altered high-density lipoprotein composition and functions during severe COVID-19
F Begue, S Tanaka, Z Mouktadi, P Rondeau, B Veeren, N Diotel, A Tran-Dinh, T Robert, E Vélia, P Mavingui, M Lagrange-Xélot, P Montravers, D Couret, O Meilhac
Scientific Reports 2021
Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases
JV Valkenburgh, C Meuret, AE Martinez, V Kodancha, V Solomon, K Chen, HN Yassine
Frontiers in physiology 2021
Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
L Schoch, L Badimon, G Vilahur
Biomedicines 2021
High-density lipoproteins, reverse cholesterol transport and atherogenesis
HJ Pownall, C Rosales, BK Gillard, AM Gotto
Nature Reviews Cardiology 2021
Good Cholesterol Gone Bad? HDL and COVID-19
GE Kluck, JA Yoo, EH Sakarya, BL Trigatti
International journal of molecular sciences 2021
Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease
J Han, X Zhang
Frontiers in Medicine 2021
CD5L as an Extracellular Vesicle-Derived Biomarker for Liquid Biopsy of Lung Cancer
ES Choi, HA Faruque, JH Kim, KJ Kim, JE Choi, BA Kim, B Kim, YJ Kim, MH Woo, JY Park, K Hur, MY Lee, DS Kim, SY Lee, E Kim
Diagnostics 2021
The Susceptibility to Diet-Induced Atherosclerosis Is Exacerbated with Aging in C57B1/6 Mice
OK Simo, H Berrougui, T Fulop, A Khalil
Biomedicines 2021
HDL-small RNA Export, Transport, and Functional Delivery in Atherosclerosis
KC Vickers, DL Michell
Current Atherosclerosis Reports 2021
Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
S Syed, E Nissilä, H Ruhanen, S Fudo, MO Gaytán, SP Sihvo, MB Lorey, J Metso, K Öörni, SJ King, OP Oommen, M Jauhiainen, S Meri, R Käkelä, K Haapasalo
iScience 2021
Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects
GE Ronsein, T Vaisar, WS Davidson, KE Bornfeldt, JL Probstfield, KD OBrien, XQ Zhao, JW Heinecke
Arteriosclerosis, thrombosis, and vascular biology 2021
Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
JT Melchior, SE Street, T Vaisar, R Hart, J Jerome, Z Kuklenyik, N Clouet-Foraison, C Thornock, S Bedi, AS Shah, JP Segrest, JW Heinecke, WS Davidson
Journal of lipid research 2021
Apolipoprotein Signature of HDL and LDL from Atherosclerotic Patients in Relation with Carotid Plaque Typology: A Preliminary Report
F Finamore, G Nieddu, S Rocchiccioli, R Spirito, A Guarino, M Formato, AJ Lepedda
Biomedicines 2021
Altered HDL Proteome Predicts Incident CVD in Chronic Kidney Disease Patients
B Shao, AV Mathew, C Thornock, S Pennathur
Journal of lipid research 2021
Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction
LY Shi, YS Han, J Chen, ZB Li, JC Li, TT Jiang
Annals of translational medicine 2021
Dietary fat and carbohydrate affect the metabolism of protein-based high-density lipoprotein subspecies
F Sacks, A Andraski
Current Opinion in Lipidology 2021
Prospective Analysis of Lipid Variations in Hyperthyroid Subjects from Lahore, Pakistan
MA Iqbal, S Ahmad, T Mumtaz, Z Naseem, J Malik, H Ahmad, N Roohi, R Mogulkoc
BioMed Research International 2021
Novel Associations between Related Proteins and Cellular Effects of High-Density Lipoprotein
S Choi, YE Park, EJ Cheon, KY Kim, M Kim, S Ann, HM Noh, J Lee, CJ Lee, ST Lee, C Lee, JE Lee, SH Lee
Korean Circulation Journal 2020
Angiogenic and Antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients
HM Li, ZW Mo, YM Peng, Y Li, WP Dai, HY Yuan, FJ Chang, TT Wang, M Wang, KH Hu, XD Li, DS Ning, YT Chen, YK Song, , Z Pei, YG Dong, ZP Wang, , YQ Xu, SM Wang, ZJ Ou, JS Ou
Redox Biology 2020
High-Density Lipoprotein Carries Markers that Track with Recovery from Stroke
DL Plubell, AM Fenton, S Rosario, P Bergstrom, PA Wilmarth, WM Clark, N Zakai, JF Quinn, J Minnier, NJ Alkayed, S Fazio, N Pamir
Circulation research 2020
Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: 2H2O-Metabolic Labeling-Based Kinetic Approach
P Sadana, L Lin, M Aghayev, S Ilchenko, T Kasumov
International journal of molecular sciences 2020
Efficient Site-Specific Prokaryotic and Eukaryotic Incorporation of Halotyrosine Amino Acids into Proteins
HS Jang, X Gu, RB Cooley, JJ Porter, RL Henson, T Willi, JA DiDonato, SL Hazen, RA Mehl
ACS chemical biology 2020
Diabetes Impairs Cellular Cholesterol Efflux from ABCA1 to Small HDL Particles
Y He, GE Ronsein, C Tang, GP Jarvik, WS Davidson, V Kothari, HD Song, J Segrest, KE Bornfeldt, JW Heinecke
Circulation research 2020
Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease
M Trinder, KR Walley, JH Boyd, LR Brunham
Arteriosclerosis, thrombosis, and vascular biology 2020
The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis
NI Díaz-Valdivia, J Díaz, P Contreras, A Campos, V Rojas-Celis, RA Burgos-Ravanal, L Lobos-González, VA Torres, VI Perez, B Frei, L Leyton, AF Quest
Oncogene 2020
Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
KG Kheniser, A Osme, C Kim, S Ilchenko, T Kasumov, SR Kashyap
Biomolecules 2020
High-density lipoproteins during sepsis: from bench to bedside
S Tanaka, D Couret, A Tran-Dinh, J Duranteau, P Montravers, A Schwendeman, O Meilhac
Critical Care 2020
Does HDL (High-Density Lipoprotein) Play a Causal Role in Host Defenses Against Infection?
JW Heinecke
Arteriosclerosis, thrombosis, and vascular biology 2020
Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities
SM Moghimi, D Simberg, E Papini, ZS Farhangrazi
Advanced Drug Delivery Reviews 2020
Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells
J Li, M Han, J Li, Z Ge, Q Wang, K Zhou, X Yin
Drug Delivery 2020
Apolipoprotein D
E Rassart, F Desmarais, O Najyb, KF Bergeron, C Mounier
Gene 2020
Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism
Y Liu, RE Morton
Current Opinion in Lipidology 2020
Calcium and hydroxyapatite binding site of human vitronectin provides insights to abnormal deposit formation
K Shin, JE Kent, C Singh, LM Fujimoto, J Yu, Y Tian, W Im, FM Marassi
Proceedings of the National Academy of Sciences 2020
Major Lipids and Future Risk of Pneumonia: 20 year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort
SS Bae, LC Chang, SS Merkin, D Elashoff, J Ishigami, K Matsushita, C Charles-Schoeman
The American Journal of Medicine 2020
Effect of niacin monotherapy on high density lipoprotein composition and function
SM Gordon, MJ Amar, K Jeiran, M Stagliano, E Staller, MP Playford, NN Mehta, T Vaisar, AT Remaley
Lipids in Health and Disease 2020
Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies
FM Sacks, L Liang, JD Furtado, T Cai, WS Davidson, Z He, RL McClelland, EB Rimm, MK Jensen
Arteriosclerosis, thrombosis, and vascular biology 2020
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
MF Santana, AL Lira, RS Pinto, CA Minanni, AR Silva, MI Sawada, ER Nakandakare, ML Correa-Giannella, MS Queiroz, GE Ronsein, M Passarelli
Lipids in Health and Disease 2020
Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein
T Okada, M Sumida, T Ohama, Y Katayama, A Saga, H Inui, K Kanno, D Masuda, M Koseki, M Nishida, Y Sakata, S Yamashita
Journal of Atherosclerosis and Thrombosis 2020
High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma
VA Kudinov, OY Alekseeva, TI Torkhovskaya, KK Baskaev, RI Artyushev, IN Saburina, SS Markin
International journal of molecular sciences 2020
Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits
T Koike, Y Koike, D Yang, Y Guo, O Rom, J Song, J Xu, Y Chen, Y Wang, T Zhu, MT Garcia-Barrio, J Fan, YE Chen, J Zhang
Atherosclerosis 2020
Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors
T Vaisar, JL Gordon, J Wimberger, JW Heinecke, AL Hinderliter, DR Rubinow, SS Girdler, KB Rubinow
Journal of Clinical Lipidology 2020
Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity
RD Lewis, AK Narayanaswamy, D Farewell, DA Rees
Clinical Endocrinology 2020
HDL from an Alzheimerʼs disease perspective:
EB Button, J Robert, TM Caffrey, J Fan, W Zhao, CL Wellington
Current Opinion in Lipidology 2019
Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study
N Nakamura, E Hatano, K Iguchi, M Sato, H Kawaguchi, I Ohtsu, T Sakurai, N Aizawa, H Iijima, S Nishiguchi, T Tomono, Y Okuda, S Wada, S Seo, K Taura, S Uemoto, M Ikegawa
BMC Cancer 2019
Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437
AV Mathew, S Pennathur
Diabetes care 2019
Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity
N Pamir, C Pan, DL Plubell, PM Hutchins, C Tang, J Wimberger, A Irwin, TQ de Aguiar Vallim, JW Heinecke, AJ Lusis
Journal of lipid research 2019
Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
LR Ruhaak, A van der Laarse, CM Cobbaert
Annals of Clinical Biochemistry 2019
Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death
P Natarajan, TS Collier, Z Jin, A Lyass, Y Li, NE Ibrahim, R Mukai, CP McCarthy, JM Massaro, RB DAgostino, HK Gaggin, C Bystrom, MS Penn, JL Januzzi
Journal of the American College of Cardiology 2019
HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation
Y Zhang, SM Gordon, , S Choi, MA Paz, R Sun, W Yang, J Saredy, M Khan, AT Remaley, JF Wang, X Yang, H Wang
Redox Biology 2019
Albuminuria, the HDL (High-Density Lipoprotein) Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus: The DCCT/EDIC Study
B Shao, LR Zelnick, J Wimberger, J Himmelfarb, J Brunzell, WS Davidson, JK Snell-Bergeon, KE Bornfeldt, IH de Boer, JW Heinecke
Arteriosclerosis, thrombosis, and vascular biology 2019
Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study
E Gourgari, J Ma, MP Playford, NN Mehta, R Goldman, AT Remaley, SM Gordon
Cardiovascular Diabetology 2019
Apolipoprotein A1 Forms 5/5 and 5/4 Antiparallel Dimers in Human High-density Lipoprotein
Y He, HD Song, GM Anantharamaiah, MN Palgunachari, KE Bornfeldt, JP Segrest, JW Heinecke
Molecular & cellular proteomics : MCP 2019
A Novel Cell-Free, Non-Fluorescent Method to Measure Lox-1- Binding Activity Corresponding to The Functional Activity of HDL
A Kakino, Y Usami, S Horiuchi, Y Fujita, K Kotani, CH Chen, T Okamura, T Sawamura
Journal of Atherosclerosis and Thrombosis 2019
Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?
MB Whyte
JRSM cardiovascular disease 2019
Deepening our understanding of HDL proteome
GE Ronsein, T Vaisar
Expert Review of Proteomics 2019
Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans
AB Andraski, SA Singh, LH Lee, H Higashi, N Smith, B Zhang, M Aikawa, FM Sacks
Arteriosclerosis, thrombosis, and vascular biology 2019
High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia
M Koch, ST DeKosky, M Goodman, J Sun, JD Furtado, AL Fitzpatrick, RH Mackey, T Cai, OL Lopez, LH Kuller, KJ Mukamal, MK Jensen
Journal of lipid research 2019
High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes
T Vaisar, JE Kanter, J Wimberger, AD Irwin, J Gauthier, E Wolfson, V Bahnam, IH Wu, H Shah, HA Keenan, CJ Greenbaum, GL King, JW Heinecke, KE Bornfeldt
Diabetes care 2019
Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
KA Riggs, PH Joshi, A Khera, K Singh, O Akinmolayemi, CR Ayers, A Rohatgi
Journal of Clinical Medicine 2019
Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk
Allyson Morton, Manja Koch, Carlos Mendivil, Jeremy Furtado, Anne Tjønneland, Kim Overvad, Liyun Wang, Majken Jensen, Frank Sacks
JCI Insight 2018
Pharmacological Intervention to Modulate HDL: What Do We Target?
NJ Woudberg, S Pedretti, S Lecour, R Schulz, N Vuilleumier, RW James, MA Frias
Frontiers in pharmacology 2018
High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography
SM Gordon, JH Chung, MP Playford, AK Dey, D Sviridov, F Seifuddin, YC Chen, M Pirooznia, MY Chen, NN Mehta, AT Remaley
Atherosclerosis 2018
Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies
JD Furtado, R Yamamoto, JT Melchior, AB Andraski, M Gamez-Guerrero, P Mulcahy, Z He, T Cai, WS Davidson, FM Sacks
Arteriosclerosis, thrombosis, and vascular biology 2018
Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within
S Kajani, S Curley, F McGillicuddy
International journal of molecular sciences 2018
Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice
J Cao, Y Xu, F Li, L Shang, D Fan, H Yu
Journal of Translational Medicine 2018
Type 2 diabetes is associated with loss of HDL endothelium protective functions
T Vaisar, E Couzens, A Hwang, M Russell, CE Barlow, LF DeFina, AN Hoofnagle, F Kim, CA Bursill
PloS one 2018
Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
G Wang, AV Mathew, H Yu, L Li, L He, W Gao, X Liu, Y Guo, J Byun, J Zhang, YE Chen, S Pennathur, X Cheng
PloS one 2018
Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease
PK Rao, K Merath, E Drigalenko, AY Jadhav, RA Komorowski, MI Goldblatt, A Rohatgi, MA Sarzynski, S Gawrieh, M Olivier
Clinical Proteomics 2018
LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans
JD Bagdade, B Jilma, LC Hudgins, P Alaupovic, CE McCurdy
Lipids in Health and Disease 2018
Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals
LT Nordestgaard, A Tybjærg-Hansen, KL Rasmussen, BG Nordestgaard, R Frikke-Schmidt
BMC Medicine 2018
Apolipoproteins and Alzheimer's pathophysiology
M Koch, ST DeKosky, AL Fitzpatrick, JD Furtado, OL Lopez, LH Kuller, RH Mackey, TM Hughes, KJ Mukamal, MK Jensen
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2018
Alteration of HDL Protein Composition with Hemodialysis Initiation
K Wang, LR Zelnick, AN Hoofnagle, T Vaisar, CM Henderson, PB Imrey, C Robinson-Cohen, IH de Boer, YT Shiu, J Himmelfarb, GJ Beck, B Kestenbaum
Clinical journal of the American Society of Nephrology : CJASN 2018
Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
SW Gui, YY Liu, XG Zhong, XY Liu, P Zheng, JC Pu, J Zhou, JJ Chen, LB Zhao, LX Liu, G Xu, P Xie
Neuropsychiatric Disease and Treatment 2018
High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease
CE Kosmas, I Martinez, A Sourlas, KV Bouza, FN Campos, V Torres, PD Montan, E Guzman
Drugs in Context 2018
From High-Density Lipoprotein Cholesterol to Measurements of FunctionHighlights: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease
FM Sacks, MK Jensen
Arteriosclerosis, thrombosis, and vascular biology 2018
High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus
Y He, V Kothari, KE Bornfeldt
Arteriosclerosis, thrombosis, and vascular biology 2018
Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study
D Li, F Huang, Y Zhao, PW Villata, TJ Griffin, L Zhang, L Li, F Yu
Clinical Proteomics 2018
Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
AV Mathew, L Li, J Byun, Y Guo, G Michailidis, M Jaiswal, YE Chen, R Pop-Busui, S Pennathur
Diabetes care 2018
Possible Insulinotropic Action of Apolipoprotein A–I Through the ABCA1/Cdc42/cAMP/PKA Pathway in MIN6 Cells
K Matsumura, N Tamasawa, M Daimon
Frontiers in Endocrinology 2018
Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol
C LowKam, D Rhainds, KS Lo, A Barhdadi, M Boulé, S Alem, V PedneaultGagnon, E Rhéaume, MP Dubé, D Busseuil, RA Hegele, G Lettre, JC Tardif
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2018
Serum and Lipoprotein Particle miRNA Profile in Uremia Patients
M Axmann, S Meier, A Karner, W Strobl, H Stangl, B Plochberger
Genes & development 2018
Plasma proteome correlates of lipid and lipoprotein: biomarkers of metabolic diversity and inflammation in children of rural Nepal
SE Lee, K Schulze, CP Stewart, RN Cole, LS Wu, A Eroglu, JD Yager, J Groopman, P Christian, KP West
Journal of lipid research 2018
Molecular Fingerprints of Iron Parameters among a Population-Based Sample
A Kaul, A Masuch, K Budde, G Kastenmüller, A Artati, J Adamski, H Völzke, M Nauck, N Friedrich, M Pietzner
Nutrients 2018
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
L Harbaum, P Ghataorhe, J Wharton, B Jiménez, LS Howard, JS Gibbs, JK Nicholson, CJ Rhodes, MR Wilkins
Thorax 2018
Plasminogen promotes cholesterol efflux by the ABCA1 pathway
Nathalie Pamir, Patrick Hutchins, Graziella E. Ronsein, Hao Wei, Riku Das, Chongren Tang, Tomas Vaisar, Edward F. Plow, Volker Schuster, Marlys L. Koschinsky, Catherine Reardon, Richard B. Weinberg, David A. Dichek, Santica Marcovina, Godfrey Getz, Jay Heinecke
JCI Insight 2017
High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis
SM Gordon, AT Remaley
Atherosclerosis 2017
High-density lipoprotein (HDL) metabolism and bone mass
NI Papachristou, HC Blair, KE Kypreos, DJ Papachristou
Journal of Endocrinology 2017
HDL cholesterol: reappraisal of its clinical relevance
W März, ME Kleber, H Scharnagl, T Speer, S Zewinger, A Ritsch, KG Parhofer, A Eckardstein, U Landmesser, U Laufs
Clinical Research in Cardiology 2017
Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL Function
CL Millar, Q Duclos, CN Blesso
Advances in nutrition (Bethesda, Md.) 2017
Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial
CJ Lee, S Choi, DH Cheon, KY Kim, EJ Cheon, S Ann, HM Noh, S Park, SM Kang, D Choi, JE Lee, SH Lee
Lipids in Health and Disease 2017
HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes
S Krishnan, M Shimoda, R Sacchi, MJ Kailemia, G Luxardi, GA Kaysen, AN Parikh, VN Ngassam, K Johansen, GM Chertow, B Grimes, JT Smilowitz, E Maverakis, CB Lebrilla, AM Zivkovic
Scientific Reports 2017
Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III
M Koch, JD Furtado, GZ Jiang, BE Gray, T Cai, F Sacks, A Tjønneland, K Overvad, MK Jensen
Journal of lipid research 2017
Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma
DK Swertfeger, H Li, S Rebholz, X Zhu, AS Shah, WS Davidson, LJ Lu
Molecular & cellular proteomics : MCP 2017
Time to ditch HDL-C as a measure of HDL function?:
GE Ronsein, JW Heinecke
Current Opinion in Lipidology 2017
Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity
E Zvintzou, M Lhomme, S Chasapi, S Filou, V Theodoropoulos, E Xapapadaki, A Kontush, G Spyroulias, CC Tellis, AD Tselepis, C Constantinou, KE Kypreos
Journal of lipid research 2017
HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants
M Holzer, S Kern, M Trieb, A Trakaki, G Marsche
Journal of lipid research 2017
High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
C Qiu, X Zhao, Q Zhou, Z Zhang
Lipids in Health and Disease 2017
Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?
B Shao, JW Heinecke
Expert Review of Proteomics 2017
Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function
P Lv, M Zhao, Y Liu, H Jin, W Cui, C Fan, Y Teng, L Zheng, Y Huang
International journal of molecular medicine 2017
Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm
E Burillo, I Jorge, D Martínez-López, E Camafeita, LM Blanco-Colio, M Trevisan-Herraz, I Ezkurdia, J Egido, JB Michel, O Meilhac, J Vázquez, JL Martin-Ventura
Scientific Reports 2016
Klinische Bedeutung des HDL-Cholesterins
W März, ME Kleber, H Scharnagl, T Speer, S Zewinger, A Ritsch, KG Parhofer, A Eckardstein, U Landmesser, U Laufs
Herz 2016
HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
Y Li, M Zhao, D He, X Zhao, W Zhang, L Wei, E Huang, L Ji, M Zhang, B Willard, Z Fu, L Wang, B Pan, L Zheng, L Ji
Lipids in Health and Disease 2016
Speciated High-Density Lipoprotein Biogenesis and Functionality
C Rosales, WS Davidson, BK Gillard, AM Gotto, HJ Pownall
Current Atherosclerosis Reports 2016
Concentration of Smaller High‐Density Lipoprotein Particle (HDL‐P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA)
DS Kim, YK Li, GA Bell, AA Burt, T Vaisar, PM Hutchins, CE Furlong, JD Otvos, JF Polak, MK Arnan, JD Kaufman, RL McClelland, WT Longstreth, GP Jarvik
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2016
Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring
SA Singh, AB Andraski, B Pieper, W Goh, CO Mendivil, FM Sacks, M Aikawa
Journal of lipid research 2016
High-density lipoproteins for therapeutic delivery systems
RK Mutharasan, L Foit, CS Thaxton
Journal of Materials Chemistry B 2016
The role of complement system in adipose tissue-related inflammation
SI Vlaicu, A Tatomir, D Boodhoo, S Vesa, PA Mircea, H Rus
Immunologic Research 2016
High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties
T Klancic, L Woodward, SM Hofmann, EA Fisher
Molecular Metabolism 2016
Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population
C Xu, Y Chen, L Xu, M Miao, Y Li, C Yu
Scientific Reports 2016
Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD
L Li, G Bebek, SF Previs, JD Smith, RG Sadygov, AJ McCullough, B Willard, T Kasumov
Journal of Proteome Research 2016
The relative merits of therapies being developed to tackle inappropriate (‘self’-directed) complement activation
S Antwi-Baffour, R Kyeremeh, JK Adjei, C Aryeh, G Kpentey
Autoimmunity Highlights 2016
Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome
SM Gordon, H Li, X Zhu, P Tso, CA Reardon, AS Shah, LJ Lu, WS Davidson
Journal of Proteomics 2016
Short- and Long-Term Effects of Weight Loss on the Complement Component C3 After Laparoscopic Gastric Bypass in Obese Patients
SÁ Gómez-Abril, C Morillas-Ariño, JL Ponce-Marco, T Torres-Sánchez, F Delgado-Gomis, A Hernández-Mijares, M Rocha
Obesity Surgery 2016
Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression
SR el Khoudary, L Wang, MM Brooks, RC Thurston, CA Derby, KA Matthews
Journal of Clinical Lipidology 2016
Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury
ES Cheow, WC Cheng, CN Lee, D Kleijn, V Sorokin, SK Sze
Molecular & cellular proteomics : MCP 2016
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
VG Flote, R Vettukattil, TF Bathen, T Egeland, A McTiernan, H Frydenberg, A Husøy, SE Finstad, J Lømo, Ø Garred, E Schlichting, EA Wist, I Thune
Lipids in Health and Disease 2016
The effects of apolipoprotein B depletion on HDL subspecies composition and function
WS Davidson, A Heink, H Sexmith, JT Melchior, SM Gordon, Z Kuklenyik, L Woollett, JR Barr, JI Jones, CA Toth, AS Shah
Journal of lipid research 2016
Systems Biology and Noninvasive Imaging of Atherosclerosis
C Calcagno, WJ Mulder, M Nahrendorf, ZA Fayad
Arteriosclerosis, thrombosis, and vascular biology 2016
Refined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity
M Holzer, S Kern, R Birner-Grünberger, S Curcic, A Heinemann, G Marsche
Scientific Reports 2016
High density lipoproteins and kidney function: the friend turned foe?
L Badimon, G Vilahur, J Cubedo
Journal of Thoracic Disease 2016
Quantitative Proteomics by Mass Spectrometry
S Sechi
Quantitative Proteomics by Mass Spectrometry 2016
High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat DietsCLINICAL PERSPECTIVE
M OReilly, E Dillon, W Guo, O Finucane, A McMorrow, A Murphy, C Lyons, D Jones, M Ryan, M Gibney, E Gibney, L Brennan, M de la Llera Moya, MP Reilly, HM Roche, FC McGillicuddy
Circulation 2016
Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation
A Cortelazzo, C de Felice, S Leoncini, C Signorini, R Guerranti, R Leoncini, A Armini, L Bini, L Ciccoli, J Hayek
Inflammation Research 2016
Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux
MF Lopez, B Krastins, DA Sarracino, G Byram, MS Vogelsang, A Prakash, S Peterman, S Ahmad, G Vadali, W Deng, I Inglessis, T Wickham, K Feeney, G Dec, I Palacios, FS Buonanno, EH Lo, MM Ning
Clinical Proteomics 2015
Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties
SM Gordon, B McKenzie, G Kemeh, M Sampson, S Perl, NS Young, MB Fessler, AT Remaley
Molecular & cellular proteomics : MCP 2015
A Novel Anti-Inflammatory Effect for High Density Lipoprotein
SJ Cameron, CN Morrell, C Bao, AM Swaim, A Rodriguez, CJ Lowenstein, J Calvert
PloS one 2015
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
J Salazar, LC Olivar, E Ramos, M Chávez-Castillo, J Rojas, V Bermúdez
Cholesterol 2015
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications
B Levkau
Frontiers in pharmacology 2015
Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?
E Niesor
Biology : open access journal 2015
Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease
CT Chang, CY Yang, FJ Tsai, SY Lin, CJ Chen
BioMed Research International 2015
Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction
X Gu, Y Huang, BS Levison, G Gerstenecker, AJ DiDonato, LB Hazen, J Lee, V Gogonea, JA DiDonato, SL Hazen
The Journal of biological chemistry 2015
α1-Antitrypsin Combines with Plasma Fatty Acids and Induces Angiopoietin-like Protein 4 Expression
E Frenzel, S Wrenger, B Brügger, S Salipalli, S Immenschuh, N Aggarwal, R Lichtinghagen, R Mahadeva, AM Marcondes, CA Dinarello, T Welte, S Janciauskiene
Journal of immunology (Baltimore, Md. : 1950) 2015
Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics
GE Ronsein, N Pamir, PD von Haller, DS Kim, MN Oda, GP Jarvik, T Vaisar, JW Heinecke
2015
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
A Hafiane, J Genest
BBA Clinical 2015
Paraoxonase-3 Is Depleted from the High-Density Lipoproteins of Autoimmune Disease Patients with Subclinical Atherosclerosis
J Marsillach, JO Becker, T Vaisar, BH Hahn, JD Brunzell, CE Furlong, IH deBoer, MA McMahon, AN Hoofnagle
Journal of Proteome Research 2015
Effect of Anti-ApoA-I Antibody-Coating of Stents on Neointima Formation in a Rabbit Balloon-Injury Model
AC Strang, ML Knetsch, LH Koole, RJ de Winter, AC van der Wal, CJ de Vries, PP Tak, RJ Bisoendial, ES Stroes, JI Rotmans, A Catapano
PloS one 2015
A Comparison of the Mouse and Human Lipoproteome: Suitability of the Mouse Model for Studies of Human Lipoproteins
S Gordon, H Li, X Zhu, A Shah, LJ Lu, WS Davidson
Journal of Proteome Research 2015
PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity
DS Kim, AA Burt, JE Ranchalis, S Vuletic, T Vaisar, WF Li, EA Rosenthal, W Dong, JF Eintracht, AG Motulsky, JD Brunzell, JJ Albers, CE Furlong, GP Jarvik
Journal of lipid research 2015
Network-Based Analysis on Orthogonal Separation of Human Plasma Uncovers Distinct High Density Lipoprotein Complexes
H Li, SM Gordon, X Zhu, J Deng, DK Swertfeger, WS Davidson, LJ Lu
Journal of Proteome Research 2015
A Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass Spectrometry
A Heink, WS Davidson, DK Swertfeger, LJ Lu, AS Shah
Journal of Proteome Research 2015
A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects
B Shao, I Boer, C Tang, PS Mayer, L Zelnick, M Afkarian, JW Heinecke, J Himmelfarb
Journal of Proteome Research 2015
Excessive centrifugal fields damage high density lipoprotein
WH Munroe, ML Phillips, VN Schumaker
Journal of lipid research 2015
SAA: a link between cholesterol efflux capacity and inflammation?
MJ Thomas, MG Sorci-Thomas
Journal of lipid research 2015
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
T Vaisar, C Tang, I Babenko, P Hutchins, J Wimberger, AF Suffredini, JW Heinecke
Journal of lipid research 2015
HIV infection induces structural and functional changes in high density lipoproteins
MO Siegel, AG Borkowska, L Dubrovsky, M Roth, R Welti, AD Roberts, DM Parenti, GL Simon, D Sviridov, S Simmens, M Bukrinsky, ML Fitzgerald
Atherosclerosis 2015
Proteomic analysis of HDL from inbred mice strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
N Pamir, P Hutchins, G Ronsein, T Vaisar, CA Reardon, GS Getz, AJ Lusis, JW Heinecke
Journal of lipid research 2015
Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice
LL Black, R Srivastava, TR Schoeb, RD Moore, S Barnes, JH Kabarowski
Journal of immunology (Baltimore, Md. : 1950) 2015
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
GE Ronsein, G Reyes-Soffer, Y He, M Oda, H Ginsberg, JW Heinecke
Molecular & cellular proteomics : MCP 2015
Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory PropertiesSignificance
SD Nguyen, K Maaninka, J Lappalainen, K Nurmi, J Metso, K Öörni, M Navab, AM Fogelman, M Jauhiainen, M Lee-Rueckert, PT Kovanen
Arteriosclerosis, thrombosis, and vascular biology 2015
Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated SubjectsSignificance
GE Ronsein, PM Hutchins, D Isquith, T Vaisar, XQ Zhao, JW Heinecke
Arteriosclerosis, thrombosis, and vascular biology 2015
Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial
T Costacou, AP Levy, RG Miller, J Snell-Bergeon, R Asleh, D Farbstein, CE Fickley, G Pambianco, R la Vega, RW Evans, TJ Orchard
Acta Diabetologica 2015
High-density lipoprotein mimetics: promises and challenges
D Sviridov, AT Remaley
Biochemical Journal 2015
Cholesteryl Ester Transfer Protein Inhibitors – Future Soon to be REVEALed
C Huggins, N Charolidi, GW Cockerill
European Cardiology Review 2015
Differential Complement Activation Pathways Promote C3b Deposition on Native and Acetylated LDL thereby Inducing Lipoprotein Binding to the Complement Receptor 1
B Klop, P der Pol, R Bruggen, Y Wang, MA de Vries, S Santen, J O'Flynn, GJ van de Geijn, TL Njo, HW Janssen, P Man, JW Jukema, TJ Rabelink, PC Rensen, C Kooten, MC Cabezas
The Journal of biological chemistry 2014
Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascade
S Mukherjee, MG Jagadeeshaprasad, T Banerjee, SK Ghosh, M Biswas, S Dutta, MJ Kulkarni, S Pattari, A Bandyopadhyay
Clinical Proteomics 2014
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation
R Duivenvoorden, J Tang, DP Cormode, AJ Mieszawska, D Izquierdo-Garcia, C Ozcan, MJ Otten, N Zaidi, ME Lobatto, SM van Rijs, B Priem, EL Kuan, C Martel, B Hewing, H Sager, M Nahrendorf, GJ Randolph, ES Stroes, V Fuster, EA Fisher, ZA Fayad, WJ Mulder
Nature Communications 2014
Modulation of adipose tissue lipolysis and body weight by high-density lipoproteins in mice
H Wei, MM Averill, TS McMillen, F Dastvan, P Mitra, S Subramanian, C Tang, A Chait, RC LeBoeuf
Nutrition and Diabetes 2014
Low LDL-C and high HDL-C levels are associated with elevated serum transaminases amongst adults in the United States: a cross-sectional study
ZG Jiang, K Mukamal, E Tapper, SC Robson, Y Tsugawa
PloS one 2014
The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins
HN Yassine, AM Jackson, CR Borges, D Billheimer, H Koh, D Smith, P Reaven, SS Lau, CH Borchers
Lipids in Health and Disease 2014
Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions
Y Tan, TR Liu, SW Hu, D Tian, C Li, JK Zhong, HG Sun, TT Luo, WY Lai, ZG Guo
PloS one 2014
Anion exchange HPLC isolation of high-density lipoprotein (HDL) and on-line estimation of proinflammatory HDL
X Ji, H Xu, H Zhang, CA Hillery, HQ Gao, KA Pritchard
PloS one 2014
A Pro-Atherogenic HDL Profile in Coronary Heart Disease Patients: An iTRAQ Labelling-Based Proteomic Approach
LR Yan, DX Wang, H Liu, XX Zhang, H Zhao, L Hua, P Xu, YS Li
PloS one 2014
Cholesterol in the retina: The best is yet to come
IA Pikuleva, CA Curcio
Progress in Retinal and Eye Research 2014
Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation
Y Yuana, J Levels, A Grootemaat, A Sturk, R Nieuwland
Journal of Extracellular Vesicles 2014
Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function
G Marsche, M Holzer, P Wolf
Experimental Dermatology 2014
Reduced apolipoprotein glycosylation in patients with the metabolic syndrome
OV Savinova, K Fillaus, L Jing, WS Harris, GC Shearer
PloS one 2014
Quantification of HDL Particle Concentration by Calibrated Ion Mobility Analysis
PM Hutchins, GE Ronsein, JS Monette, N Pamir, J Wimberger, Y He, GM Anantharamaiah, DS Kim, JE Ranchalis, GP Jarvik, T Vaisar, JW Heinecke
Clinical chemistry 2014
HDL-3 is a Superior Predictor of Carotid Artery Disease in a Case-Control Cohort of 1725 Participants
DS Kim, AA Burt, EA Rosenthal, JE Ranchalis, JF Eintracht, TS Hatsukami, CE Furlong, S Marcovina, JJ Albers, GP Jarvik
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2014
The application of multiple reaction monitoring to assess ApoA-I methionine oxidations in diabetes and cardiovascular disease
HN Yassine, AM Jackson, PD Reaven, D Nedelkov, RW Nelson, SS Lau, CH Borchers
Translational Proteomics 2014
Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies
PH Joshi, PP Toth, ST Lirette, ME Griswold, JM Massaro, SS Martin, MJ Blaha, KR Kulkarni, AA Khokhar, A Correa, RB D'Agustino, SR Jones
EUR J PREV CARDIOL 2014
Quantification of HDL Proteins, Cardiac Events, and Mortality in Patients with Type 2 Diabetes on Hemodialysis
C Kopecky, B Genser, C Drechsler, V Krane, CC Kaltenecker, M Hengstschlager, W Marz, C Wanner, MD Saemann, T Weichhart
Clinical journal of the American Society of Nephrology : CJASN 2014
Restoration of Renal Function Does Not Correct Impairment of Uremic HDL Properties
C Kopecky, M Haidinger, R Birner-Grunberger, B Darnhofer, CC Kaltenecker, G Marsche, M Holzer, T Weichhart, M Antlanger, JJ Kovarik, J Werzowa, M Hecking, MD Saemann
Journal of the American Society of Nephrology : JASN 2014
A Retained Secretory Signal Peptide Mediates High Density Lipoprotein (HDL) Assembly and Function of Haptoglobin-related Protein
JM Harrington, T Nishanova, SR Pena, M Hess, CL Scelsi, J Widener, SL Hajduk
The Journal of biological chemistry 2014
HDL in CKD: How Good Is the "Good Cholesterol?"
IH de Boer, JD Brunzell
Journal of the American Society of Nephrology : JASN 2014
Higher HDL Cholesterol Is Associated with Better Cognitive Function: the Maine-Syracuse Study
GE Crichton, MF Elias, A Davey, KJ Sullivan, MA Robbins
Journal of the International Neuropsychological Society : JINS 2014
Myeloperoxidase, paraoxonase-1 and HDL form a functional ternary complex
Ying Huang, Zhiping Wu, Meliana Riwanto, Shengqiang Gao, Bruce Levison, Xiaodong Gu, Xiaoming Fu, Matthew Wagner, Christian Besler, Gary Gerstenecker, Renliang Zhang, Xin-Min Li, Anthony DiDonato, Valentin Gogonea, W.H. Wilson Tang, Jonathan D. Smith, Edward F. Plow, Paul L. Fox, Diana Shih, Aldons Lusis, Edward A Fisher, Joseph DiDonato, Ulf Landmesser, Stanley L. Hazen
Journal of Clinical Investigation 2013
HDL and endothelial protection
A Tran-Dinh, D Diallo, S Delbosc, LM Varela-Perez, QB Dang, B Lapergue, E Burillo, JB Michel, A Levoye, JL Martin-Ventura, O Meilhac
British Journal of Pharmacology 2013
Genetic and Structure-Function Studies of Missense Mutations in Human Endothelial Lipase
H Razzaghi, A Tempczyk-Russell, K Haubold, SA Santorico, T Shokati, U Christians, ME Churchill, O El-Maarri
PloS one 2013
HDL and cholesterol: life after the divorce?
KC Vickers, AT Remaley
Journal of lipid research 2013
Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: Potential applications to cardiovascular disease and diabetes
H Yassine, CR Borges, MR Schaab, D Billheimer, C Stump, P Reaven, SS Lau, R Nelson
PROTEOMICS - CLINICAL APPLICATIONS 2013
Function and Distribution of Apolipoprotein A1 in the Artery Wall Are Markedly Distinct From Those in Plasma
JA DiDonato, Y Huang, KS Aulak, O Even-Or, G Gerstenecker, V Gogonea, Y Wu, PL Fox, WH Tang, EF Plow, JD Smith, EA Fisher, SL Hazen
Circulation 2013
Why Targeting HDL Should Work as a Therapeutic Tool, but Hasn’t:
MG Sorci-Thomas, MJ Thomas
Journal of Cardiovascular Pharmacology 2013
HDL endocytosis and resecretion☆
C Röhrl, H Stangl
Biochimica et Biophysica Acta 2013
SUBRETINAL DRUSENOID DEPOSITS IN NON-NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Morphology, Prevalence, Topography, and Biogenesis Model
CA Curcio, JD Messinger, KR Sloan, G McGwin, NE Medeiros, RF Spaide
Retina 2013
HDL—is it too big to fail?
DS Ng, NC Wong, RA Hegele
Nature Reviews Endocrinology 2013
Inflammation and atherosclerosis: direct versus indirect mechanisms
ME Rosenfeld
Current Opinion in Pharmacology 2013
Novel Mechanisms of Action of the Biologicals in Rheumatic Diseases
CB Chighizola, EG Favalli, PL Meroni
Clinical Reviews in Allergy & Immunology 2013
Mild hypercholesterolemia blunts the proinflammatory and prothrombotic effects of hypertension on the cerebral microcirculation
SF Rodrigues, SA Vital, DN Granger
Journal of Cerebral Blood Flow & Metabolism 2013
Aging affects high-density lipoprotein composition and function
M Holzer, M Trieb, V Konya, C Wadsack, A Heinemann, G Marsche
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013
Importance of high-density lipoprotein quality: evidence from chronic kidney disease
V Kon, TA Ikizler, S Fazio
Current Opinion in Nephrology and Hypertension 2013
High-density lipoproteins delivering interleukin-15
MC Ochoa, I Melero, P Berraondo
OncoImmunology 2013
Sphingomyelin in high-density lipoproteins: structural role and biological function
R Martínez-Beamonte, JM Lou-Bonafonte, MV Martínez-Gracia, J Osada
International journal of molecular sciences 2013
Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice
L Brocca, A Mascaro, G D'Antona
Journal of the International Society of Sports Nutrition 2013
High-Density Lipoproteins and the Immune System
H Kaji
Journal of Lipids 2013
Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles
D Nguyen, M Nickel, C Mizuguchi, H Saito, S Lund-Katz, MC Phillips
Biochemistry 2013
CONSERVATION of APOLIPOPROTEIN A-I’s CENTRAL DOMAIN STRUCTURAL ELEMENTS UPON LIPID ASSOCIATION ON DIFFERENT HDL SUBCLASSES
MN Oda, MS Budamagunta, EG Geier, SH Chandradas, B Shao, JW Heinecke, JC Voss, G Cavigiolio
Biochemistry 2013
Progranulin: at the interface of neurodegenerative and metabolic diseases
AD Nguyen, TA Nguyen, LH Martens, LL Mitic, RV Farese
Trends in Endocrinology & Metabolism 2013
Biochemical and Functional Characterization of Charge-Defined Subfractions of High-Density Lipoprotein From Normal Adults
JY Hsieh, CT Chang, MT Huang, CM Chang, CY Chen, MY Shen, HY Liao, GJ Wang, CH Chen, CJ Chen, CY Yang
Analytical Chemistry 2013
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker
AJ Lepedda, G Nieddu, E Zinellu, PD Muro, F Piredda, A Guarino, R Spirito, F Carta, F Turrini, M Formato
Oxidative Medicine & Cellular Longevity 2013
Effects of ω-3 polyunsaturated fatty acids on plasma proteome in Rett syndrome
CD Felice, A Cortelazzo, C Signorini, R Guerranti, S Leoncini, A Pecorelli, T Durand, JM Galano, C Oger, G Zollo, B Montomoli, C Landi, L Bini, G Valacchi, L Ciccoli, J Hayek
Mediators of Inflammation 2013
HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process
M Sanson, E Distel, EA Fisher
PloS one 2013
Dyslipidemia links obesity to early cerebral neurochemical alterations
AP Haley, MM Gonzales, T Tarumi, H Tanaka
Obesity 2013
Secreted progranulin is a homodimer and is not a component of high density lipoproteins (HDL)
AD Nguyen, TA Nguyen, B Cenik, G Yu, J Herz, TC Walther, WS Davidson, RV Farese
The Journal of biological chemistry 2013
High density lipoprotein structure, function, and metabolism: a new Thematic Series
KA Rye
Journal of lipid research 2013
The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth
SM Gordon, WS Davidson, EM Urbina, LM Dolan, A Heink, H Zang, LJ Lu, AS Shah
Diabetes 2013
Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
AS Shah, L Tan, JL Long, WS Davidson
Journal of lipid research 2013
Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies
Jere P Segrest, Marian C Cheung, Martin K Jones
Journal of lipid research 2013
MD simulations suggest important surface differences between reconstituted and circulating spherical HDL
JP Segrest, MK Jones, A Catte
Journal of lipid research 2013
A Comparison of the Theoretical Relationship between HDL Size and the Ratio of HDL Cholesterol to Apolipoprotein A-I with Experimental Results from the Women's Health Study
NA Mazer, F Giulianini, NP Paynter, P Jordan, S Mora
Clinical chemistry 2013
New roles of HDL in inflammation and hematopoiesis
X Zhu, JS Parks
Annual Review of Nutrition 2012
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport
RS Rosenson, HB Brewer, WS Davidson, ZA Fayad, V Fuster, J Goldstein, M Hellerstein, XC Jiang, MC Phillips, DJ Rader, AT Remaley, GH Rothblat, AR Tall, L Yvan-Charvet
Circulation 2012
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
C Besler, TF Lüscher, U Landmesser
EMBO Molecular Medicine 2012
The emerging role of HDL in glucose metabolism
BG Drew, KA Rye, SJ Duffy, P Barter, BA Kingwell
Nature Reviews Endocrinology 2012
Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy
XQ Zhao, WS Kerwin
Clinical Lipidology 2012
Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels
H Razzaghi, SA Santorico, MI Kamboh
Frontiers in Genetics 2012
Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein
TJ Sontag, R Carnemolla, T Vaisar, CA Reardon, GS Getz
Journal of lipid research 2012
HDL dysfunction in diabetes: causes and possible treatments
D Farbstein, AP Levy
Expert Review of Cardiovascular Therapy 2012
Serum Amyloid A in Uremic HDL Promotes Inflammation
T Weichhart, C Kopecky, M Kubicek, M Haidinger, D Döller, K Katholnig, C Suarna, P Eller, M Tölle, C Gerner, GJ Zlabinger, M van der Giet, WH Hörl, R Stocker, MD Säemann
Journal of the American Society of Nephrology : JASN 2012
The structure of dimeric apolipoprotein A-IV and its mechanism of self-association
X Deng, J Morris, J Dressmen, MR Tubb, P Tso, WG Jerome, WS Davidson, TB Thompson
Structure (London, England : 1993) 2012
BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α
DA Rodriguez, S Zamorano, F Lisbona, D Rojas-Rivera, H Urra, JR Cubillos-Ruiz, R Armisen, DR Henriquez, EH Cheng, M Letek, T Vaisar, T Irrazabal, C Gonzalez-Billault, A Letai, FX Pimentel-Muiños, G Kroemer, C Hetz
The EMBO Journal 2012
Monocyte-to-Macrophage Differentiation
MY Chang, CK Chan, KR Braun, PS Green, KD O'Brien, A Chait, AJ Day, TN Wight
The Journal of biological chemistry 2012
The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients
G Aragonès, P Pardo-Reche, L Fernández-Sender, A Rull, R Beltrán-Debón, E Rodríguez-Gallego, J Camps, J Joven, C Alonso-Villaverde
Mediators of Inflammation 2012
Identification of Fibrin Clot-Bound Plasma Proteins
S Talens, FW Leebeek, JA Demmers, DC Rijken
PloS one 2012
Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
T Nakayama, JS Butler, A Sehgal, M Severgnini, T Racie, J Sharman, F Ding, SS Morskaya, J Brodsky, L Tchangov, V Kosovrasti, M Meys, L Nechev, G Wang, CG Peng, Y Fang, M Maier, KG Rajeev, R Li, J Hettinger, S Barros, V Clausen, X Zhang, Q Wang, R Hutabarat, NV Dokholyan, C Wolfrum, M Manoharan, V Kotelianski, M Stoffel, DW Sah
Molecular Therapy 2012
HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach
A Mangé, A Goux, S Badiou, L Patrier, B Canaud, T Maudelonde, JP Cristol, J Solassol
PloS one 2012
Unique Proteomic Signatures Distinguish Macrophages and Dendritic Cells
L Becker, NC Liu, MM Averill, W Yuan, N Pamir, Y Peng, AD Irwin, X Fu, KE Bornfeldt, JW Heinecke
PloS one 2012
The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice
WR Lagor, DW Fields, SA Khetarpal, A Kumaravel, W Lin, N Weintraub, K Wu, SF Hamm-Alvarez, D Drazul-Schrader, M la Llera-Moya, GH Rothblat, DJ Rader
PloS one 2012
Understanding Postprandial Inflammation and Its Relationship to Lifestyle Behaviour and Metabolic Diseases
B Klop, SD Proctor, JC Mamo, KM Botham, MC Cabezas
International Journal of Vascular Medicine 2012
The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk?
JW Heinecke
Nature Medicine 2012
An analysis of functional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation
H Inoshita, I Ohsawa, K Onda, M Tamano, S Horikoshi, H Ohi, Y Tomino
Clinical Kidney Journal 2012
Lipids and HCV
MF Bassendine, DA Sheridan, SH Bridge, DJ Felmlee, RD Neely
Seminars in Immunopathology 2012
High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA-I Dysfunctionality
A Onat, G Can, E Örnek, E Ayhan, N Erginel-Ünaltuna, SN Murat
Lipids 2012
Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome
E Burillo, R Mateo-Gallego, A Cenarro, S Fiddyment, AM Bea, I Jorge, J Vázquez, F Civeira
Lipids in Health and Disease 2012
Psoriasis alters HDL composition and cholesterol efflux capacity
M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, D El-Gamal, C Wadsack, A Heinemann, G Marsche
Journal of lipid research 2012
Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
KB Rubinow, T Vaisar, C Tang, AM Matsumoto, JW Heinecke, ST Page
Journal of lipid research 2012
Using bioinformatics and systems genetics to dissect HDL-cholesterol genetics in an MRL/MpJ x SM/J intercross
MS Leduc, RH Blair, RA Verdugo, SW Tsaih, K Walsh, GA Churchill, B Paigen
Journal of lipid research 2012
Impact of Mifepristone, a Glucocorticoid/Progesterone Antagonist, on HDL Cholesterol, HDL Particle Concentration, and HDL Function
ST Page, RM Krauss, C Gross, B Ishida, JW Heinecke, C Tang, JK Amory, PM Schaefer, CJ Cox, J Kane, JQ Purnell, RL Weinstein, T Vaisar
The Journal of clinical endocrinology and metabolism 2012
Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures
AN Hoofnagle, JO Becker, MN Oda, G Cavigiolio, P Mayer, T Vaisar
Clinical chemistry 2012
Acute Sex Steroid Withdrawal Increases Cholesterol Efflux Capacity and HDL-Associated Clusterin in Men
KB Rubinow, C Tang, AN Hoofnagle, CN Snyder, JK Amory, JW Heinecke, ST Page
Steroids 2012
Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins
K Gauthamadasa, NS Vaitinadin, JL Dressman, S Macha, R Homan, KD Greis, RA Silva
The Journal of biological chemistry 2012
Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones
MN Martinez, CH Emfinger, M Overton, S Hill, TS Ramaswamy, DA Cappel, K Wu, S Fazio, WH McDonald, DL Hachey, DL Tabb, JM Stafford
Journal of lipid research 2012
Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities
KM Ali, A Wonnerth, K Huber, J Wojta
British Journal of Pharmacology 2012
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
S Kunnen, MV Eck
Journal of lipid research 2012
Crystal structures of cholesteryl ester transfer protein in complex with inhibitors
S Liu, A Mistry, JM Reynolds, DB Lloyd, MC Griffor, DA Perry, RB Ruggeri, RW Clark, X Qiu
The Journal of biological chemistry 2012
Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
B Yu, C Wu, S Zhao
Journal of lipid research 2012
New insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolism
MC Phillips
Journal of lipid research 2012
Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease
MK Jensen, EB Rimm, JD Furtado, FM Sacks
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2012
High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism: Novel Hypotheses and Review of Literature
M Navab, ST Reddy, BJ Lenten, GM Buga, G Hough, AC Wagner, AM Fogelman
Arteriosclerosis, thrombosis, and vascular biology 2012
Cholesterol Accumulation Regulates Expression of Macrophage Proteins Implicated in Proteolysis and Complement Activation
M Suzuki, L Becker, DK Pritchard, SA Gharib, EM Wijsman, TK Bammler, RP Beyer, T Vaisar, JF Oram, JW Heinecke
Arteriosclerosis, thrombosis, and vascular biology 2012
Proteomics investigations of HDL: challenges and promise.
Vaisar T
Current vascular pharmacology 2012
Progress and challenges in translating the biology of atherosclerosis
P Libby, PM Ridker, GK Hansson
Nature 2011
Site-specific Oxidation of Apolipoprotein A-I Impairs Cholesterol Export by ABCA1, a Key Cardioprotective Function of HDL
B Shao
Biochimica et Biophysica Acta 2011
Impact of HDL Oxidation by the Myeloperoxidase System on Sterol Efflux by the ABCA1 Pathway
B Shao, JW Heinecke
Journal of Proteomics 2011
Regulation of ABCA1 Functions by Signaling Pathways
Y Liu, C Tang
Biochimica et Biophysica Acta 2011
A Systems Genetic Analysis of High Density Lipoprotein Metabolism and Network Preservation across Mouse Models
P Langfelder, LW Castellani, Z Zhou, E Paul, R Davis, EE Schadt, AJ Lusis, S Horvath, M Mehrabian
Biochimica et Biophysica Acta 2011
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
R Kones
Drug design, development and therapy 2011
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
M Navab, ST Reddy, BJ Lenten, AM Fogelman
Nature Reviews Cardiology 2011
Complement in age-related macular degeneration: a focus on function
DT Bradley, PF Zipfel, AE Hughes
Eye 2011
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
AV Khera, M Cuchel, M la Llera-Moya, A Rodrigues, MF Burke, K Jafri, BC French, JA Phillips, ML Mucksavage, RL Wilensky, ER Mohler, GH Rothblat, DJ Rader
The New England journal of medicine 2011
High-density lipoprotein proteome dynamics in human endotoxemia
JH Levels, P Geurts, H Karlsson, R Marée, S Ljunggren, L Fornander, L Wehenkel, M Lindahl, ES Stroes, JA Kuivenhoven, JC Meijers
Proteome Science 2011
A practical approach to lipid management in the elderly
A Viljoen
The journal of nutrition, health & aging 2011
CETP Inhibition: Does the Future Look Promising?
PP Toth
Current Cardiology Reports 2011
Lipid parameters for measuring risk of cardiovascular disease
BJ Arsenault, SM Boekholdt, JJ Kastelein
Nature Reviews Cardiology 2011
Apo A-I Modulating Therapies
SJ Nicholls
Current Cardiology Reports 2011
Urine Glycoprotein Profile Reveals Novel Markers for Chronic Kidney Disease
A Vivekanandan-Giri, JL Slocum, CL Buller, V Basrur, W Ju, R Pop-Busui, DM Lubman, M Kretzler, S Pennathur
International Journal of Proteomics 2011
Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
GS Getz, CA Reardon
Journal of inflammation research 2011
Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function
D Bashtovyy, MK Jones, GM Anantharamaiah, JP Segrest
Journal of lipid research 2011
Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage[S]
X Wang, S Li, Y Bai, X Fan, K Sun, J Wang, R Hui
Journal of lipid research 2011
HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution
Y Zheng, AB Patel, V Narayanaswami, GL Hura, B Hang, JK Bielicki
Biochemistry 2011
Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma
R Huang, RA Silva, WG Jerome, A Kontush, MJ Chapman, LK Curtiss, TJ Hodges, WS Davidson
Nature Structural & Molecular Biology 2011
Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3
M Biedzka-Sarek, J Metso, A Kateifides, T Meri, TS Jokiranta, A Muszyński, J Radziejewska-Lebrecht, V Zannis, M Skurnik, M Jauhiainen
The Journal of biological chemistry 2011
Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes
C Morgantini, A Natali, B Boldrini, S Imaizumi, M Navab, AM Fogelman, E Ferrannini, ST Reddy
Diabetes 2011
Vitamin E therapy results in a reduction in HDL function in individuals with Diabetes and the Haptoglobin 2-1 genotype
D Farbstein, S Blum, M Pollak, R Asaf, HL Viener, O Lache, R Asleh, R Miller-Lotan, I Barkay, M Star, A Schwartz, S Kalet-Littman, D Ozeri, J Vaya, H Tavori, M Vardi, A Laor, SE Bucher, Y Anbinder, D Moskovich, N Abbas, N Perry, Y Levy, AP Levy
Atherosclerosis 2011
Uremia Alters HDL Composition and Function
M Holzer, R Birner-Gruenberger, T Stojakovic, D El-Gamal, V Binder, C Wadsack, A Heinemann, G Marsche
Journal of the American Society of Nephrology : JASN 2011
Status and Prospects for Discovery and Verification of New Biomarkers of Cardiovascular Disease by Proteomics
RE Gerszten, A Asnani, SA Carr, JV Eyk
Circulation research 2011
Dense Genotyping of Candidate Gene Loci Identifies Variants Associated With High-Density Lipoprotein Cholesterol
AC Edmondson, PS Braund, IM Stylianou, AV Khera, CP Nelson, ML Wolfe, SL DerOhannessian, BJ Keating, L Qu, J He, MD Tobin, M Tomaszewski, J Baumert, N Klopp, A Döring, B Thorand, M Li, MP Reilly, W Koenig, NJ Samani, DJ Rader
Circulation. Cardiovascular genetics 2011
Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency
P Miarka, B Idzior-Waluś, M Kuźniewski, M Waluś-Miarka, T Klupa, W Sułowicz
Clinical and Experimental Nephrology 2011
Myeloperoxidase-dependent inactivation of surfactant protein D in vitro and in vivo
EC Crouch, TO Hirche, B Shao, R Boxio, J Wartelle, R Benabid, B McDonald, J Heinecke, S Matalon, A Belaaouaj
The Journal of biological chemistry 2010
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
M Vergeer, AG Holleboom, JJ Kastelein, JA Kuivenhoven
Journal of lipid research 2010
Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis
H Inoshita, I Ohsawa, G Kusaba, M Ishii, K Onda, S Horikoshi, H Ohi, Y Tomino
BMC Nephrology 2010
The protein cargo of HDL: implications for vascular wall biology and therapeutics
JW Heinecke
Journal of Clinical Lipidology 2010
Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol
L Yetukuri, S Söderlund, A Koivuniemi, T Seppänen-Laakso, PS Niemelä, M Hyvönen, MR Taskinen, I Vattulainen, M Jauhiainen, M Oresic
Journal of lipid research 2010
HDL Lipids and Insulin Resistance
AN Hoofnagle, T Vaisar, P Mitra, A Chait
Current Diabetes Reports 2010
Anti-oxidant properties of high-density lipoprotein and atherosclerosis
EA Podrez
Clinical and Experimental Pharmacology and Physiology 2010
Pharmacomodulation of High-Density Lipoprotein Metabolism as a Therapeutic Intervention for Atherosclerotic Disease
PP Toth
Current Cardiology Reports 2010
A Macrophage Sterol-Responsive Network Linked to Atherogenesis
L Becker, SA Gharib, AD Irwin, E Wijsman, T Vaisar, JF Oram, JW Heinecke
Cell Metabolism 2010
Glycosylation and Sialylation of Macrophage-derived Human Apolipoprotein E Analyzed by SDS-PAGE and Mass Spectrometry
Y Lee, M Kockx, MJ Raftery, W Jessup, R Griffith, L Kritharides
Molecular & cellular proteomics : MCP 2010
HDL in humans with cardiovascular disease exhibits a proteomic signature
T Vaisar, P Mayer, E Nilsson, XQ Zhao, R Knopp, BJ Prazen
Clinica chimica acta; international journal of clinical chemistry 2010
Dysfunctional HDL as a Diagnostic and Therapeutic Target
JD Smith
Arteriosclerosis, thrombosis, and vascular biology 2010
Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry
MT Mazur, HL Cardasis, DS Spellman, A Liaw, NA Yates, RC Hendrickson
Proceedings of the National Academy of Sciences 2010
Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: A strategy to distinguish patients with preeclampsia from matching control individuals
U Pecks, F Seidenspinner, C Röwer, T Reimer, W Rath, MO Glocker
Journal of the American Society for Mass Spectrometry 2010
High-density lipoprotein and the acute phase response
A Jahangiri
Current Opinion in Endocrinology, Diabetes and Obesity 2010
High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality
S Gordon, A Durairaj, JL Lu, WS Davidson
Current Cardiovascular Risk Reports 2010
Biological properties of apolipoprotein a-I mimetic peptides
GS Getz, GD Wool, CA Reardon
Current Atherosclerosis Reports 2010
An immune response network associated with blood lipid levels
M Inouye, K Silander, E Hamalainen, V Salomaa, K Harald, P Jousilahti, S Männistö, JG Eriksson, J Saarela, S Ripatti, M Perola, GJ van Ommen, MR Taskinen, A Palotie, ET Dermitzakis, L Peltonen
PLoS genetics 2010
The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins
HS Courtney, HJ Pownall
Journal of biomedicine & biotechnology 2010
Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry
LA Collins, M Olivier
Proteome Science 2010
The major yolk protein vitellogenin interferes with the anti-plasmodium response in the malaria mosquito Anopheles gambiae
MK Rono, MM Whitten, M Oulad-Abdelghani, EA Levashina, E Marois
PLoS Biology 2010
Effects of diet on genetic regulation of lipoprotein metabolism in baboons
DL Rainwater, JL VandeBerg, MC Mahaney
Atherosclerosis 2010
High Density Lipoprotein (HDL) Cholesterol: Leveraging Practice-Based Biobank Cohorts to Characterize Clinical and Genetic Predictors of Treatment Outcome
RA Wilke
The Pharmacogenomics Journal 2010
Apolipoprotein Mimetic Peptides: Mechanisms of Action as Anti-atherogenic Agents
DO Osei-Hwedieh, M Amar, D Sviridov, AT Remaley
Pharmacology & Therapeutics 2010
Proteomic Analysis of Human Serum for Finding Pathogenic Factors and Potential Biomarkers in Preeclampsia
C Liu, N Zhang, H Yu, Y Chen, Y Liang, H Deng, Z Zhang
Placenta 2010
Dysfunctional, pro-inflammatory HDL directly upregulate monocyte PDGFRβ, chemotaxis and TNFα production
BJ Skaggs, BH Hahn, L Sahakian, J Grossman, M McMahon
Clinical Immunology 2010
Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides: Implications for Antiatherogenic Activities of High-Density Lipoprotein
W D'Souza, JA Stonik, A Murphy, SJ Demosky, AA Sethi, XL Moore, J Chin-Dusting, AT Remaley, D Sviridov
Circulation research 2010
High-Density Lipoprotein Suppresses the Type I Interferon Response, a Family of Potent Antiviral Immunoregulators, in Macrophages Challenged With Lipopolysaccharide
M Suzuki, DK Pritchard, L Becker, AN Hoofnagle, N Tanimura, TK Bammler, RP Beyer, R Bumgarner, T Vaisar, MC de Beer, FC de Beer, K Miyake, JF Oram, JW Heinecke
Circulation 2010
Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
L Yvan-Charvet, J Kling, T Pagler, H Li, B Hubbard, T Fisher, CP Sparrow, AK Taggart, AR Tall
Arteriosclerosis, thrombosis, and vascular biology 2010
Low Clusterin Levels in High-Density Lipoprotein Associate With Insulin Resistance, Obesity, and Dyslipoproteinemia
AN Hoofnagle, M Wu, AK Gosmanova, JO Becker, EM Wijsman, JD Brunzell, SE Kahn, RH Knopp, TJ Lyons, JW Heinecke
Arteriosclerosis, thrombosis, and vascular biology 2010
Speciated Human High-Density Lipoprotein Protein Proximity Profiles
K Gauthamadasa, C Rosales, HJ Pownall, S Macha, WG Jerome, R Huang, RA Silva
Biochemistry 2010
Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration Chromatography
SM Gordon, J Deng, LJ Lu, WS Davidson
Journal of Proteome Research 2010
Phospholipid Transfer Protein in Human Plasma Associates with Proteins Linked to Immunity and Inflammation
MC Cheung, T Vaisar, X Han, JW Heinecke, JJ Albers
Biochemistry 2010
Drug Treatment of Hyperlipidaemia: A Guide to the Rational Use of Lipid-Lowering Drugs
PP Toth
Drugs 2010
Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
Viljoen A, Wierzbicki AS
Drug, healthcare and patient safety 2010
HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property
G Ortiz-Muñoz, X Houard, JL Martín-Ventura, BY Ishida, S Loyau, P Rossignol, JA Moreno, JP Kane, RJ Chalkley, AL Burlingame, JB Michel, O Meilhac
The FASEB Journal 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
MJ Chapman, WL Goff, M Guerin, A Kontush
European Heart Journal 2009
The macrophage: the intersection between HIV infection and atherosclerosis
SM Crowe, CL Westhorpe, N Mukhamedova, A Jaworowski, D Sviridov, M Bukrinsky
Journal of leukocyte biology 2009
Inflammation induces fibrinogen nitration in experimental human endotoxemia
SP Heffron, I Parastatidis, M Cuchel, ML Wolfe, MG Tadesse, ER 3rd, H Ischiropoulos, DJ Rader, MP Reilly
Free radical biology & medicine 2009
Myeloperoxidase: An Oxidative Pathway for Generating Dysfunctional High-Density Lipoprotein
B Shao, MN Oda, JF Oram, JW Heinecke
Chemical Research in Toxicology 2009
Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins
AN Hoofnagle, JW Heinecke
Journal of lipid research 2009
Macrophage Scavenger Receptor A Mediates Adhesion to Apolipoproteins A-I and E
C Neyen, A Plüddemann, P Roversi, B Thomas, L Cai, DR van der Westhuyzen, RB Sim, S Gordon
Biochemistry 2009
MMP-9 Sheds the β2 Integrin Subunit (CD18) from Macrophages
T Vaisar, SY Kassim, IG Gomez, PS Green, S Hargarten, PJ Gough, WC Parks, CL Wilson, EW Raines, JW Heinecke
Molecular & cellular proteomics : MCP 2009
Inflammation Impairs Reverse Cholesterol Transport In Vivo
FC McGillicuddy, ML la Moya, CC Hinkle, MR Joshi, EH Chiquoine, JT Billheimer, GH Rothblat, MP Reilly
Circulation 2009
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins
CA Curcio, M Johnson, JD Huang, M Rudolf
Progress in Retinal and Eye Research 2009
Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis
C Charles-Schoeman, J Watanabe, YY Lee, DE Furst, S Amjadi, D Elashoff, G Park, M McMahon, HE Paulus, AM Fogelman, ST Reddy
Arthritis & Rheumatism 2009
Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry
LA Collins, SP Mirza, AH Kissebah, M Olivier
Physiological genomics 2009
Thematic review series: proteomics. Proteomic analysis of lipid-protein complexes
T Vaisar
Journal of lipid research 2009
The HDL proteome: a marker--and perhaps mediator--of coronary artery disease
JW Heinecke
Journal of lipid research 2009
Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein
JM Harrington, S Howell, SL Hajduk
The Journal of biological chemistry 2009
Developments in the clinical understanding of lupus
MK Crow
Arthritis Research & Therapy 2009
The role of dysfunctional HDL in atherosclerosis
M Navab, ST Reddy, BJ van Lenten, GM Anantharamaiah, AM Fogelman
Journal of lipid research 2009
Chylomicrons promote intestinal absorption and systemic dissemination of dietary antigen (ovalbumin) in mice
Y Wang, S Ghoshal, M Ward, W Villiers, J Woodward, E Eckhardt
PloS one 2009
Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland
K Wu, C Joffre, X Li, M MacVeigh-Aloni, M Hom, J Hwang, C Ding, S Gregoire, L Bretillon, JF Zhong, SF Hamm-Alvarez
Experimental Eye Research 2009
Bioactive TGF-beta can associate with lipoproteins and is enriched in those containing apolipoprotein E3
I Tesseur, H Zhang, W Brecht, J Corn, JS Gong, K Yanagisawa, M Michikawa, K Weisgraber, Y Huang, T Wyss-Coray
Journal of Neurochemistry 2009
Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation
NH Moore, LG Costa, SA Shaffer, DR Goodlett, M Guizzetti
Journal of Neurochemistry 2009
HDL as a Biomarker, Potential Therapeutic Target, and Therapy
M Navab, GM Anantharamaiah, ST Reddy, BJ van Lenten, AM Fogelman
Diabetes 2009
HDL Remodeling During the Acute Phase Response
A Jahangiri, MC de Beer, V Noffsinger, LR Tannock, C Ramaiah, NR Webb, DR van der Westhuyzen, FC de Beer
Arteriosclerosis, thrombosis, and vascular biology 2009
Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function
WS Davidson, RA Silva, S Chantepie, WR Lagor, MJ Chapman, A Kontush
Arteriosclerosis, thrombosis, and vascular biology 2009
Overexpression of Apolipoprotein F Reduces HDL Cholesterol Levels In Vivo
WR Lagor, RJ Brown, SA Toh, JS Millar, IV Fuki, M de la Llera-Moya, T Yuen, G Rothblat, JT Billheimer, DJ Rader
Arteriosclerosis, thrombosis, and vascular biology 2009
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction.
Schwartz A, Blum S, Asleh R, Pollak M, Kalet-Litman S, Levy AP
Pharmacogenomics and Personalized Medicine 2009
Dysfunctional high-density lipoprotein.
Feng H, Li XA
Current opinion in endocrinology, diabetes, and obesity 2009
Host-derived oxidized phospholipids and high density lipoprotein regulate innate immunity in mycobacterial infection
Daniel Cruz, Andrew D. Watson, Christopher S. Miller, Dennis Montoya, Maria-Teresa Ochoa, Peter A. Sieling, Miguel A. Gutierrez, Mohamad Navab, Srinivasa T. Reddy, Joseph L. Witztum, Alan M. Fogelman, Thomas H. Rea, David Eisenberg, Judith Berliner, and Robert L. Modlin
Journal of Clinical Investigation 2008
Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome
PS Green, T Vaisar, S Pennathur, JJ Kulstad, AB Moore, S Marcovina, J Brunzell, RH Knopp, XQ Zhao, JW Heinecke
Circulation 2008
HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications
AT Remaley, M Amar, D Sviridov
Expert Review of Cardiovascular Therapy 2008
Determinants of variation in human serum paraoxonase activity
DL Rainwater, S Rutherford, TD Dyer, ED Rainwater, SA Cole, JL Vandeberg, L Almasy, J Blangero, JW Maccluer, MC Mahaney
Heredity 2008
Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex
Y He, DJ Greene, M Kinter, RE Morton
Journal of lipid research 2008
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
BH Hahn, J Grossman, BJ Ansell, BJ Skaggs, M McMahon
Arthritis Research & Therapy 2008
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M Lundqvist, J Stigler, G Elia, I Lynch, T Cedervall, KA Dawson
Proceedings of the National Academy of Sciences 2008
Localized-statistical quantification of human serum proteome associated with type 2 diabetes
RX Li, HB Chen, K Tu, SL Zhao, H Zhou, SJ Li, J Dai, QR Li, S Nie, YX Li, WP Jia, R Zeng, JR Wu
PloS one 2008
Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes
RA Silva, R Huang, J Morris, J Fang, EO Gracheva, G Ren, A Kontush, WG Jerome, KA Rye, WS Davidson
Proceedings of the National Academy of Sciences 2008
When good cholesterol turns bad: The evolving saga of CETP inhibitors and clinical strategies to elevate high-density lipoprotein
JF Oram, JW Heinecke
Current Diabetes Reports 2008
Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
R Asleh, S Blum, S Kalet-Litman, J Alshiek, R Miller-Lotan, R Asaf, W Rock, M Aviram, U Milman, C Shapira, Z Abassi, AP Levy
Diabetes 2008
Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: Consequences for atherosclerosis development
GM Dallinga-Thie, RP Dullaart, A van Tol
Current Diabetes Reports 2008
Apolipoprotein D in Lipid Metabolism and Its Functional Implication in Atherosclerosis and Aging
Perdomo G, Dong HH
Aging 2008
Proteomic Biomarkers of Atherosclerosis
Vivanco F, Padial LR, Darde VM, de la Cuesta F, Alvarez-Llamas G, Diaz-Prieto N, Barderas MG
Biomarker insights 2008
HDL proteomics: Pot of gold or Pandora's box?
Muredach P. Reilly1 and Alan R. Tall2
Journal of Clinical Investigation 2007
Myeloperoxidase and inflammatory proteins: Pathways for generating dysfunctional high-density lipoprotein in humans
T Vaisar, B Shao, PS Green, MN Oda, JF Oram, JW Heinecke
Current Atherosclerosis Reports 2007
Inflammatory proteins on HDL: What are we measuring?
KD O'Brien
Translational Research 2007
SELDI-TOF mass spectrometry of High-Density Lipoprotein
JH Levels, B Bleijlevens, F Rezaee, JM Aerts, JC Meijers
Proteome Science 2007
When good cholesterol turns bad: The evolving saga of CETP inhibitors and clinical strategies to elevate high-density lipoprotein
JF Oram, JW Heinecke
Current Atherosclerosis Reports 2007
HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease
HB Brewer
Current Cardiology Reports 2007

← Previous 1 2 3 … 16 17 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 7 patents
Referenced in 1 Wikipedia pages
Highlighted by 1 platforms
287 readers on Mendeley
2 readers on CiteULike
See more details